News Owlstone's breath-based lung cancer diagnostic could save 10... Trial's next phase will recruit 3,000 patients across 21 international sites.
News Exercise prescription platform Physitrack selected for Londo... Web and app-based solution lets doctors prescribe post-operation recovery exercise programmes.
Views & Analysis A novel UK approach to cancer access: yes, no, or maybe? Experts discuss the implications of the new, reinvigorated Cancer Drugs Fund, for pharma and patients.
News London digital health accelerator unveils first start-ups 32 digital health companies selected to take part in DigitalHealth.London Accelerator programme.
Views & Analysis Digital Health Round-up – the NHS’ digitisation; worldwide w... A round-up of this week’s top digital healthcare news. Marco Ricci reports.
News ‘Perverse disincentives’ blocking NHS from taking up innovat... Can the NHS adopt and spread innovation faster?
News EU clears first drug therapy for rare disease cALD Neuraxpharm and Minoryx' Nezglyal has become the first approved drug therapy in the EU for rare neurodegenerative disease cALD.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
